FinTok developed by Fiadm s.r.o. · future of webapps

Ostatné · TWST

Twist Bioscience Corporation

202,85 14,18 (+7,52 %) aktualizované práve teraz
1 týždeň+12,9 %
1 mesiac+62,6 %
3 mesiace+103,0 %
1 rok+552,9 %
52t minimum25,45
52t maximum202,85
RSI 1475
SMA 50137,97
SMA 20077,92

Fundamenty firmy Healthcare · Biotechnology · United States

Hodnotenie 0–10, vypočítané z údajov firmy

Finančná siladlh voči vlastnému kapitálu, likvidita
10
Ziskovosťmarže, návratnosť kapitálu (ROE)
0
Rastrast tržieb a ziskov
9
OcenenieP/E, PEG, P/B – vyššie = lacnejšie
0

Orientačné skóre v štýle GuruFocus – nie je to odporúčanie.

Analytici 12 hodnotení

nákup

Najnižší cieľ
36,00
Priemerný cieľ
120,83
Najvyšší cieľ
212,00
Potenciál
−40,4 %
2731

silný nákup · nákup · držať · predaj · silný predaj

Oceniť v DCF kalkulačke →
Trhová kapitalizácia ?13,4 mld. P/E ?– P/E budúce ?-269,9 PEG ?– P/B ?28,5 EV/EBITDA ?-102,1 Dividendový výnos ?– Čistá marža ?-31,7 % ROE ?-29,6 % Dlh / vlastný kapitál ?24 % Rast tržieb ?+23,2 % Rast ziskov ?– Voľný cash flow ?-64,8 mil. Tržby ?431,8 mil. Beta ?2,19 Podiel inštitúcií ?117 %

Odhad zisku na akciu (EPS)

ObdobieOdhadRozpätiePred rokomRast
tento štvrťrok-0,15-0,38–-0,02-0,45+67,5 %
budúci štvrťrok-0,16-0,38–-0,04-0,50+68,3 %
tento rok-0,96-2,04–-0,57-2,12+54,6 %
budúci rok-0,75-2,05–0,10-0,96+21,7 %

Odhad tržieb

ObdobieOdhadPred rokomRast
tento štvrťrok123,6 mil.99,0 mil.+24,8 %
budúci štvrťrok125,8 mil.103,7 mil.+21,3 %
tento rok456,4 mil.376,6 mil.+21,2 %
budúci rok540,5 mil.456,4 mil.+18,4 %

Nákupy a predaje manažérov insider

KtoČoHodnotaDátum
Cho DennisOfficer predaj 57 59121.09.
Green PaulaOfficer predaj 48 65421.09.
Leproust Emily MChief Executive Officer predaj 279 18321.09.
Leproust Emily MChief Executive Officer predaj 56,3 mil.17.09.
Leproust Emily MChief Executive Officer uplatnenie opcií 4,2 mil.17.09.
Cho DennisOfficer predaj 50 52108.09.
Werner Robert F.Officer predaj 29 18508.09.
Green PaulaOfficer predaj 111 22008.09.
Leproust Emily MChief Executive Officer predaj 282 28008.09.
Leproust Emily MChief Executive Officer predaj 6,3 mil.25.08.
Werner Robert F.Officer predaj 213 25524.08.
Finn Patrick JohnPresident predaj 562 66121.08.

Predaje manažérov sú bežné (dane, diverzifikácia); nákupy z vlastných peňazí bývajú silnejší signál.

Kto vlastní akcie

Slávni investori: Cathie Wood · 3.0 % Ray Dalio · 0.0 % · nový

Blackrock Inc.9,30 %

Artisan Partners Limited Partnership7,66 %

FMR, LLC7,50 %

ARK Investment Management, LLC7,26 %

Price (T.Rowe) Associates Inc5,80 %

State Street Corporation5,15 %

Vanguard Portfolio Management LLC4,51 %

Vanguard Capital Management LLC4,30 %

O firme (popis z Yahoo Finance, anglicky)

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc and Lilly TuneLab. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

https://www.twistbioscience.com ↗

Názor AI

Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.

Technické signály

Odporúčania

K tomuto aktívu zatiaľ nemáme odporúčanie.

Predikcie

Žiadne predikcie.

Súvisiace správy

Žiadne správy so značkou TWST.